Abstract:We conducted a laboratory comparison trial involving 12 international laboratories to test the technical aspects of DNA methylation data generation and profile interpretation. Participants received a DNA aliquot of four low‐grade gliomas and performed the DNA methylation‐based classification and result interpretation without knowledge of histology, interpreted the copy number profiles and conducted DNA sequencing of the BRAF hotspot p.V600. Results showed a high technical reproducibility with a median pairwise correlation of 0.99 (range 0.94–0.99) between coordinating laboratory and participants. Aims DNA methylation profiling, recently endorsed by the World Health Organisation (WHO) as a pivotal diagnostic tool for brain tumours, most commonly relies on bead arrays. Despite its widespread use, limited data exist on the technical reproducibility and potential cross‐institutional differences. The LOGGIC Core BioClinical Data Bank registry conducted a prospective laboratory comparison trial with 12 international laboratories to enhance diagnostic accuracy for paediatric low‐grade gliomas, focusing on technical aspects of DNA methylation data generation and profile interpretation under clinical real‐time conditions. Methods Four representative low‐grade gliomas of distinct histologies were centrally selected, and DNA extraction was performed. Participating laboratories received a DNA aliquot and performed the DNA methylation‐based classification and result interpretation without knowledge of tumour histology. Additionally, participants were required to interpret the copy number profile derived from DNA methylation data and conduct DNA sequencing of the BRAF hotspot p.V600 due to its relevance for low‐grade gliomas. Results had to be returned within 30 days. Results High technical reproducibility was observed, with a median pairwise correlation of 0.99 (range 0.94–0.99) between coordinating laboratory and participants. DNA methylation‐based tumour classification and copy number profile interpretation were consistent across all centres, and BRAF mutation status was accurately reported for all cases. Eleven out of 12 centres successfully reported their analysis within the 30‐day timeframe. Conclusion Our study demonstrates remarkable concordance in DNA methylation profiling and profile interpretation across 12 international centres. These findings underscore the potential contribution of DNA methylation analysis to the harmonisation of brain tumour diagnostics.

Rapid DNA methylation-based classification of pediatric brain tumors from ultrasonic aspirate specimens

PATH-01. ACCURATE AND RAPID PAEDIATRIC BRAIN TUMOR CLASSIFICATION (PBT) BY METHYLATION PROFILING USING NOVEL NATIVE REAL TIME OXFORD NANOPORE TECHNOLOGY SEQUENCING TECHNOLOGY

Diagnosis of pediatric central nervous system tumors using methylation profiling of cfDNA from cerebrospinal fluid

Biom-19. Methylation Profiling Of Plasma Cell-Free Dna In Pediatric Brain Tumor Patients

Towards accesible brain-tumor classification at the point of care: Nanopore methylation sequencing from Formalin-Fixed Paraffin-Embedded (FFPE) pathology samples

Machine-learning operations streamlined clinical workflows of DNA methylation-based CNS tumor classification.

Rapid Intraoperative Amplicon Sequencing of CNS Tumor Markers

Reliable tumor detection by whole-genome methylation sequencing of cell-free DNA in cerebrospinal fluid of pediatric medulloblastoma

Comparison of DNA methylation based classification models for precision diagnostics of central nervous system tumors

Toward intraoperative tissue classification: exploiting signal feedback from an ultrasonic aspirator for brain tissue differentiation

Diagnostic classification based on DNA methylation profiles using sequential machine learning approaches.

Unclassifiable CNS tumors in DNA methylation-based classification: clinical challenges and prognostic impact

DNA methylation-based epigenetic signatures predict somatic genomic alterations in gliomas

Rapid identification of pediatric brain tumors with differential mobility spectrometry

DNA methylation-based classification of malformations of cortical development in the human brain

Transcriptome profiling of pediatric extracranial solid tumors and lymphomas enables rapid low-cost diagnostic classification

A Fast, Affordable, and Minimally Invasive Diagnostic Test for Cancer of Unknown Primary Using DNA Methylation Profiling

DNA methylation-based classification of central nervous system tumours

Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes

DNA methylation‐array interlaboratory comparison trial demonstrates highly reproducible paediatric CNS tumour classification across 13 international centres

Lipidomic-Based Approach to 10 s Classification of Major Pediatric Brain Cancer Types with Picosecond Infrared Laser Mass Spectrometry